Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Published:2015-07-15 Issue:20 Volume:121 Page:3631-3638
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim W. Ray¹,Loomba Rohit²,Berg Thomas³,Aguilar Schall Raul E.⁴,Yee Leland J.⁴,Dinh Phillip V.⁴,Flaherty John F.⁴,Martins Eduardo B.⁴,Therneau Terry M.⁵,Jacobson Ira⁶,Fung Scott⁷,Gurel Selim⁸,Buti Maria⁹,Marcellin Patrick¹⁰

Affiliation:

1. Division of Gastroenterology and Hepatology; Stanford University School of Medicine; Palo Alto California

2. Divisions of Gastroenterology and Epidemiology; University of California at San Diego; La Jolla California

3. Section of Hepatology, Division of Gastroenterology and Rheumatology, Department of Internal Medicine; University of Leipzig; Leipzig Germany

4. Gilead Sciences Inc; Foster City California

5. Department of Biostatistics; Mayo Clinic; Rochester Minnesota

6. Division of Gastroenterology and Hepatology; Weill Cornell Medical College; New York New York

7. Department of Gastroenterology; University of Toronto; Toronto Ontario Canada

8. Department of Gastroenterology; Uludag University Medical School; Bursa Turkey

9. Liver Unit; University Hospital Vall d'Hebron and Institute Ciberehd Carlos III; Barcelona Spain

10. Hepatology Service, Beaujon Hospital; Paris-Diderot University and INSERM CRI/UMR 1149; Viral Hepatitis Research Centre Clichy France

Funder

Atlantic Philanthropies Inc

The John A. Hartford Foundation

The Association of Specialty Professors

The American Gastroenterological Association

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29537/fullpdf

Reference28 articles.

1. World Health Organization WHO Fact Sheet No. 204 on Hepatitis B 2013 http://www.who.int/mediacentre/factsheets/fs204/en/

2. Hepatitis B virus infection;Lee;N Engl J Med.,1997

3. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology.,2012

4. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study;Loomba;Am J Epidemiol.,2013

5. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma;Loomba;Clin Gastroenterol Hepatol.,2013

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation;Journal of Virology;2024-02-05

2. A new approach to prevent, diagnose, and treat hepatitis B in Africa;BMC Global and Public Health;2023-11-02

3. Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety;American Journal of Gastroenterology;2023-10-09

4. Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B;JHEP Reports;2023-10

5. Five-year results of a treatment program for chronic hepatitis B in Ethiopia;BMC Medicine;2023-09-29